The University of Chicago Header Logo

Connection

Russell D. Cohen to Certolizumab Pegol

Back to Details
This is a "connection" page, showing publications Russell D. Cohen has written about Certolizumab Pegol.
Russell D. Cohen
Connection Strength
0.127
Certolizumab Pegol
  1. Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease. Inflamm Bowel Dis. 2014 Oct; 20(10):1722-8.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.